QNTM: מזומנים בחישוב למניה אחת quantumbiopharma.com

Quantum BioPharma Ltd (QNTM) relies on patents that allow for the scaling of R&D without incurring unnecessary costs. The company develops phytochemical agents in Israel and Canada for the treatment of inflammation. However, the underutilization of extraction facilities and a market decline in prices are driving up the cost of goods sold. This GURU.Markets chart of cash per share illustrates liquidity trends, where the latest value is recorded as 1.42.
פילוחי מדדים מקיפים ואנליטיקה עבור Quantum BioPharma (QNTM)

The indicator is calculated as the ratio of liquid assets to the number of shares outstanding. This metric objectively links market value to the company's actual cash reserves per share. For Quantum BioPharma Ltd (QNTM), such funds are generated through stable licensing royalties from inflammation therapy patents. This ensures the business's financial stability during recessionary periods. By analyzing the cash per share trend, an investor determines the company's margin of safety.